Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB): Results from segregation analysis in families with premature coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2729-2736

  Juo, Suh Hang Hank ^a,c   Beaty, Terri H ^a   Kwiterovich Jr , Peter O ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Coronary artery disease; Etiologic heterogeneity; Familial combined hyperlipidemia; HyperapoB; Segregation analysis

Indexed keywords

APOLIPOPROTEIN B;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILIAL DISEASE; FEMALE; GENOTYPE; HUMAN; HYPERAPOBETALIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SEGREGATION ANALYSIS;

EID: 0031459891     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2729     Document Type: Article

References (12)

1. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density β lipoproteins). Proc Natl Acad Sci U S A. 1980;77:604-608.
2. Kwiterovich PO Jr, Coresh J, Bachorik PS. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged <50 years) and women (<60 years) with coronary artery disease. Am J Cardiol. 1993;71:631-639.
3. Sniderman A, Teng B, Genest J, Cianflone K, Wacholder S, Kwiterovich PO Jr. Familial aggregation and early expression of hyperapobetalipoproteinemia. Am J Cardiol. 1985;55:291-295.
4. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich PO Jr, Wacholder S, Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984;311: 1329-1332.
5. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PW, Salem DN, Schaefer EJ. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85:2025-2033.
6. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52: 1544-1568.
7. Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO Jr. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982;97:833-839.
8. Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet. 1986;2:592-595.
9. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
10. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, Barlow GK, Stephenson SH, Lalouel JM, Kuida H. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988;259:3579-3586.
11. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR. Apolipoprotein, low-density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989;9:335-344.
12. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.